6.00
-0.56(-8.54%)
Currency In USD
Previous Close | 6.56 |
Open | 5.86 |
Day High | 6.65 |
Day Low | 5.72 |
52-Week High | 3,756 |
52-Week Low | 5.16 |
Volume | 284,090 |
Average Volume | 579,056 |
Market Cap | 3.4M |
PE | 0 |
EPS | -3,442.8 |
Moving Average 50 Days | 8.39 |
Moving Average 200 Days | 654.02 |
Change | -0.56 |
If you invested $1000 in GlucoTrack, Inc. (GCTK) 10 years ago, it would be worth $0.02 as of July 01, 2025 at a share price of $6. Whereas If you bought $1000 worth of GlucoTrack, Inc. (GCTK) shares 5 years ago, it would be worth $0.21 as of July 01, 2025 at a share price of $6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire Inc.
Jun 25, 2025 12:30 PM GMT
Comprehensive analysis confirms safety and strong accuracy of Glucotrack's innovative blood-based continuous glucose monitoring technology, with MARD of 7.7%RUTHERFORD, N.J. and STOCKHOLM, June 25, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq:
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
GlobeNewswire Inc.
Jun 12, 2025 1:05 PM GMT
1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused o
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire Inc.
Jun 04, 2025 12:30 PM GMT
Glucotrack to present on next-generation continuous blood glucose monitoring technology in Innovation Hub Poster presentation to highlight insights on safety and performance data from direct blood glucose measurement technology RUTHERFORD, N.J., Jun